| 摘要 |
#CMT# #/CMT# Preparation of antigen against HIV and hepatitis C virus (HCV) involves: capturing virus particles in capsules adsorbed in intestines such that the virus is left in its own environment by blocking the integrase enzyme to induce primary and secondary immune reactions; enclosing same quantity of virus particles in capsules such that inactivity of reverse transcriptase enzyme is achieved and is orally used after becoming inactivated; and recognizing the weakened virus particles in HIV or HCV infections. #CMT#ACTIVITY : #/CMT# Anti-HIV; Virucide; Hepatotropic; Antiinflammatory. #CMT#MECHANISM OF ACTION : #/CMT# Vaccine. No biological data given. #CMT#USE : #/CMT# For the preparation of antigens against viremia, particularly HIV and HCV infections. #CMT#ADVANTAGE : #/CMT# The cause of the humoral immune reaction failure is eliminated; sensibility of the immune system against HIV is reduced so that the antigen induces oral tolerance. Immunity is provided 4-5 months. #CMT#ADMINISTRATION : #/CMT# As oral vaccine. No dosage given. |
